CLINICAL PROFILE OF MULTIPLE MYELOMA IN A TERTIARY CARE HOSPITAL OF PESHAWAR, PAKISTAN

被引:1
作者
Basharat, Shifa [1 ]
Batool, Zufishan [1 ]
Ali, Nosheen [1 ]
机构
[1] Rehman Med Coll, Pathol Dept, Peshawar, Pakistan
来源
KHYBER MEDICAL UNIVERSITY JOURNAL-KMUJ | 2019年 / 11卷 / 03期
关键词
Multiple Myeloma (MeSH); Anemia (MeSH); Renal impairment (Non-MeSH); Kidney Diseases (MeSH); Hypercalcemia (MeSH); Thrombocytopenia (MeSH); Hypoalbuminemia (MeSH); Bone Marrow (MeSH); Myeloma Proteins (MeSH); POPULATION;
D O I
10.35845/kmuj.2019.18790
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To determine demographic and clinico-pathological characteristics of patients suffering from multiple myeloma (MM) in Peshawar, Pakistan. METHODS: This descriptive, retrospective study was conducted at Pathology Department, Rehman Medical Institute, Peshawar, Pakistan from January 2006 to September 2018. Detailed information of forty patients diagnosed with MM was collected. World Health Organization (WHO) set criterion was utilized to diagnose MM. SPSS version 22 was used for Statistical analysis. RESULTS: Out of 40 patients, 72.5% were males with male to female ratio of 2.63: 1 and mean age of patients was 59.26 +/- 13.1 years. The common presenting complaints were body/bony pain (87.5%), fatigue (72.5%), body tenderness (45%) and backache (42.5%). Pallor was present in 33 (82.5%) patients. Laboratory studies showed mean hemoglobin level of 8.6 +/- 2.1 g/dl, anemia (92.5%), thrombocytopenia (27.5%) and hypercalcemia (17.5%). Elevated ESR >100 was noted in 29 (72.5%) cases. Renal impairment was established in 35% of patients. Urinary Bence Jones protein was present in 13 (32.5%). Serum protein electrophoresis showed M band in 39 (97.5%) cases. Lytic lesions were detected in X-rays of 31 (77.5%) patients. Based on international staging system, nine (22.5%) cases were in stage I, 16 (40%) in stage II and 15 (37.5%) in stage III. CONCLUSION: Majority of multiple myeloma patients in our study were in ththe 6 decade of life. Bone pain and fatigue were the most common presenting symptoms. Anemia and elevated ESR were the most common laboratory parameter. Most of the patients were diagnosed in later stages (stage II and III).
引用
收藏
页码:152 / 155
页数:4
相关论文
共 18 条
  • [1] [Anonymous], 2008, WHO CLASSIFICATION T
  • [2] Basit Abdul, 2014, J Ayub Med Coll Abbottabad, V26, P376
  • [3] Devi A A., 2017, J Sci Soc, V44, P140, DOI DOI 10.4103/JSS.JSS_42_17
  • [4] ERIKSSON M, 1992, BRIT J IND MED, V49, P95
  • [5] Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI [10.1001/jamaoncol.2016.5688, 10.1001/jamaoncol.2018.2706]
  • [6] Clinical Profile of Multiple Myeloma in South India
    Fousad, Chemban
    Gangadharan, K., V
    Abdulla, Mansoor C.
    Naryan, Ram
    Ali, M. Jesha Mohammed
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2018, 39 (01) : 62 - 66
  • [7] Kaur P, 2014, Gulf J Oncolog, V1, P14
  • [8] Review of 1027 patients with newly diagnosed multiple myeloma
    Kyle, RA
    Gertz, MA
    Witzig, TE
    Lust, JA
    Lacy, MQ
    Dispenzieri, A
    Fonseca, R
    Rajkumar, SV
    Offord, JR
    Larson, DR
    Plevak, ME
    Therneau, TM
    Greipp, PR
    [J]. MAYO CLINIC PROCEEDINGS, 2003, 78 (01) : 21 - 33
  • [9] Anion gap among patients of multiple myeloma and normal individuals
    Mansoor, Shireen
    Siddiqui, Imran
    Adil, Salman
    Kakepoto, Ghulam Nabi
    Fatmi, Zafar
    Ghani, Farooq
    [J]. CLINICAL BIOCHEMISTRY, 2007, 40 (3-4) : 226 - 229
  • [10] International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
    Rajkumar, S. Vincent
    Dimopoulos, Meletios A.
    Palumbo, Antonio
    Blade, Joan
    Merlini, Giampaolo
    Mateos, Maria-Victoria
    Kumar, Shaji
    Hillengass, Jens
    Kastritis, Efstathios
    Richardson, Paul
    Landgren, Ola
    Paiva, Bruno
    Dispenzieri, Angela
    Weiss, Brendan
    Leleu, Xavier
    Zweegman, Sonja
    Lonial, Sagar
    Rosinol, Laura
    Zamagni, Elena
    Jagannath, Sundar
    Sezer, Orhan
    Kristinsson, Sigurdur Y.
    Caers, Jo
    Usmani, Saad Z.
    Lahuerta, Juan Jose
    Johnsen, Hans Erik
    Beksac, Meral
    Cavo, Michele
    Goldschmidt, Hartmut
    Terpos, Evangelos
    Kyle, Robert A.
    Anderson, Kenneth C.
    Durie, Brian G. M.
    San Miguel, Jesus F.
    [J]. LANCET ONCOLOGY, 2014, 15 (12) : E538 - E548